Related Experiment Video
Updated: Nov 29, 2025

08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
6.4K
ESHRE guideline: female fertility preservation
, Richard A Anderson1, Frédéric Amant2,3,4
1MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK.
Human Reproduction Open
|November 23, 2020
Summary
This guideline offers 78 recommendations for fertility preservation (FP) in women and transgender men, covering care, information, assessment, interventions, and post-treatment. It addresses growing demand for FP options across diverse patient groups.
Area of Science:
- Reproductive Medicine and Endocrinology
- Oncology Supportive Care
- Gender-Affirming Care
Background:
- The field of fertility preservation (FP) has expanded significantly due to increased recognition of fertility loss as a side effect of cancer treatments and advancements in oocyte vitrification and ovarian tissue cryopreservation (OTC).
- Provision of FP services for young women has become more widespread, though access remains uneven.
Purpose of the Study:
- To provide recommended management for fertility preservation in women and transgender men based on the best available scientific literature.
- To offer clear advice on best practices in female FP, addressing a growing demand from diverse patient populations.
Main Methods:
- Development of the guideline followed a structured methodology by the European Society of Human Reproduction and Embryology (ESHRE).
- Key questions were formulated by experts, followed by comprehensive literature searches and assessments of papers published up to November 1, 2019.
- Recommendations were formulated through expert consensus and underwent a stakeholder review before final approval.
Main Results:
- The guideline presents 78 recommendations covering organization of care, information provision, pre-FP assessment, FP interventions, and after-treatment care.
- Includes 50 evidence-based recommendations (31 strong, 19 weak), 25 good practice points, and 3 research-only recommendations.
- Addresses FP needs for patients undergoing gonadotoxic treatments (cancer, benign diseases), those with genetic conditions, transgender men, and women seeking oocyte cryopreservation for age-related loss.
Conclusions:
- The guideline offers clinicians evidence-based advice on female FP, acknowledging that many interventions require further study, particularly regarding pregnancy outcomes.
- Highlights the need for more research in FP, especially for techniques like OTC and in vitro maturation (IVM), to refine current recommendations.
- Provides a list of research recommendations to stimulate further investigation in the field of female fertility preservation.
Related Concept Videos
Infertility in Females
3.5K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
3.5K
Infertility in Males
433
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
433
Spermatogenesis
113.0K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
113.0K

